Inactive Instrument

Spring Pharmaceutical Group, Inc.

BYC

US84987P1057

China YCT International Group, Inc. has Changed its Name to Spring Pharmaceutical Group, Inc

August 31, 2018 at 09:30 am IST

On August 31, 2018, China YCT International Group, Inc. changed its name to Spring Pharmaceutical Group, Inc.

Latest news about Spring Pharmaceutical Group, Inc.

Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	15/19/15	CI
Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	13/18/13	CI
China YCT International Group, Inc. has Changed its Name to Spring Pharmaceutical Group, Inc	31/18/31	CI
China YCT International Group, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2018	15/18/15	CI
China YCT International Group, Inc Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	15/17/15	CI
China YCT International Group, Inc Announces Financial Results for the Year Ending March 31, 2017	12/17/12	CI
China YCT International Group, Inc Appoints Li Dong to the Board of Directors	24/17/24	CI
Shandong Yongchuntang Group Co., Ltd acquired 3% stake in Shandong Spring Pharmaceutical Co., Ltd. from China YCT International Group, Inc.	28/17/28	CI
China YCT International Group Inc. Reports Earnings Results for the Fiscal Year Ended March 31, 2015	16/15/16	CI
CYIG Signs Strategic Cooperation Agreement with Xi'an Putian Pharmacy	15/14/15	CI
China YCT International Group, Inc Reports Earnings Results for the Year Ended March 31, 2014	22/14/22	CI
L.Y.(HK) Biotech Limited cancelled the acquisition of China YCT International Group, Inc in a reverse merger transaction.	29/12/29	CI

Chart Spring Pharmaceutical Group, Inc.

Duration

Period

More charts

SPRING PHARMACEUTICAL GROUP, INC., formerly China YCT International Group, Inc., operates through two of its subsidiaries, Landway Nano Bio-Tech Group, Inc. (Landway Nano) and Shandong Spring Pharmaceutical Co., Ltd. (Shandong Spring Pharmaceutical). Through its subsidiaries, the Company is engaged in the distribution of health care supplement products, and in the development, manufacture and sales of Huoliyuan capsules, and in the development of the acer truncatum bunge planting bases and selling acer truncatum seed oil.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B

Other Pharmaceuticals